stomach pain weight loss fatigue

This item was filled under [ Most Popular ]

Adding Multimedia FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced the U.S. Food and Drug Administration (FDA) has approved Herceptin® (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not …
Lapband Week 3 Post-op: Food & Strange ???

Be Sociable, Share!
Tags: , , , , , , , , , ,
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.



#